Bachleda Mark 4
4 · Lyell Immunopharma, Inc. · Filed Jun 11, 2025
Insider Transaction Report
Form 4
Bachleda Mark
Director
Transactions
- Award
Option (right to buy)
2025-06-09+13,000→ 13,000 totalExercise: $12.47Exp: 2035-06-08→ Common Stock (13,000 underlying)
Footnotes (1)
- [F1]1/36th of the shares of Common Stock subject to the option shall vest on a monthly basis following the grant date on the same day of the month as such grant date (or on the last day of the month, if there is no corresponding day in such month), subject to the Reporting Person remaining in service as a director through the applicable vesting date.